Laurel Wealth Advisors (North Carolina)’s ESSA Pharma EPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-600
Closed -$948 331
2025
Q1
$948 Hold
600
﹤0.01% 640
2024
Q4
$1.07K Hold
600
﹤0.01% 660
2024
Q3
$3.64K Hold
600
﹤0.01% 550
2024
Q2
$3.16K Hold
600
﹤0.01% 523
2024
Q1
$5.09K Hold
600
﹤0.01% 485
2023
Q4
$3.96K Hold
600
﹤0.01% 471
2023
Q3
$1.85K Hold
600
﹤0.01% 514
2023
Q2
$1.62K Hold
600
﹤0.01% 523
2023
Q1
$1.78K Hold
600
﹤0.01% 523
2022
Q4
$1.51K Hold
600
﹤0.01% 498
2022
Q3
$1K Hold
600
﹤0.01% 509
2022
Q2
$2K Hold
600
﹤0.01% 529
2022
Q1
$4K Hold
600
﹤0.01% 499
2021
Q4
$9K Hold
600
﹤0.01% 418
2021
Q3
$5K Hold
600
﹤0.01% 473
2021
Q2
$17K Hold
600
﹤0.01% 396
2021
Q1
$17K Hold
600
﹤0.01% 366
2020
Q4
$7K Hold
600
﹤0.01% 436
2020
Q3
$4K Hold
600
﹤0.01% 434
2020
Q2
$4K Hold
600
﹤0.01% 430
2020
Q1
$2K Hold
600
﹤0.01% 466
2019
Q4
$3K Hold
600
﹤0.01% 472
2019
Q3
$2K Hold
600
﹤0.01% 472
2019
Q2
$1K Hold
600
﹤0.01% 498
2019
Q1
$2K Hold
600
﹤0.01% 454
2018
Q4
$1K Buy
+600
New +$1.76K ﹤0.01% 478

Other funds holding EPIX